ZOLL EPCR IOS

K131919 · ZOLL Medical Corporation · DXJ · Dec 17, 2013 · Cardiovascular

Device Facts

Record IDK131919
Device NameZOLL EPCR IOS
ApplicantZOLL Medical Corporation
Product CodeDXJ · Cardiovascular
Decision DateDec 17, 2013
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 870.2450
Device ClassClass 2
AttributesSoftware as a Medical Device

Indications for Use

ZOLL ePCR iOS is intended for the collection, storage and printing of patient data that is entered by a user (caregiver), or captured from specified medical devices, and integrated into a patient care report (patient electronic medical record). ZOLL ePCR iOS is intended for use by qualified medical personnel providing direct patient care in the pre-hospital environment to document the care provided. ZOLL ePCR iOS is indicated for use by health care providers whenever there is a need for generation of a patient record.

Device Story

ZOLL ePCR iOS is a software-only medical data collection system; runs on Apple iOS devices (iPads/iPhones). Collects, stores, and prints patient data entered by caregivers or captured from specified medical devices; integrates data into patient care reports (electronic medical records). Used by qualified medical personnel in pre-hospital environments to document care. Synchronizes with data servers via wireless/network connections to import or access records. Non-alarming software; facilitates clinical documentation and record generation; supports patient care management by providing a centralized electronic record of pre-hospital interventions.

Clinical Evidence

No clinical data. Substantial equivalence supported by extensive performance testing demonstrating the device performs as well as the predicate and meets all functional requirements.

Technological Characteristics

Software-only application; runs on Apple iOS operating system. Connectivity via wireless or network to synchronize with data servers. Non-alarming. Designed for data collection, storage, and printing of patient records.

Indications for Use

Indicated for use by qualified medical personnel providing direct patient care in the pre-hospital environment to document care via patient electronic medical records.

Regulatory Classification

Identification

A medical cathode-ray tube display is a device designed primarily to display selected biological signals. This device often incorporates special display features unique to a specific biological signal.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains two logos. On the left is the logo for the Department of Health & Human Services - USA, featuring a stylized human figure. To the right is the logo for the U.S. Food & Drug Administration (FDA), with the FDA acronym in a blue square and the full name "U.S. FOOD & DRUG ADMINISTRATION" in blue text next to it. ZOLL Medical Corporation, Worldwide Headquarters Shannon Duhamel Regulatory Affairs Specialist 269 Mill Road Chelmsford, Massachusetts 01824-4105 September 1, 2023 Re: K131919 Trade/Device Name: ZOLL ePCR iOS Regulation Number: 21 CFR 870.2450 Regulation Name: Medical Cathode-ray Tube Display Regulatory Class: Class II Product Code: DXJ Dear Shannon Duhamel: The Food and Drug Administration (FDA) is sending this letter to notify you of an administrative change related to your previous substantial equivalence (SE) determination letter dated December 17, 2013. Specifically, FDA is updating this SE Letter to remove the secondary product code NSX as an administrative correction. Please note that the 510(k) submission was not re-reviewed. For questions regarding this letter, please contact Aneesh Deoras, OHT2: Office of Cardiovascular Devices, 240-402-4363, Aneesh.Deoras@fda.hhs.gov. Sincerely, Aneesh S. Deoras -S for Jennifer Shih Kozen Assistant Director Division of Cardiac Electrophysiology, Diagnostics, and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle or bird-like figure with outstretched wings. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 December 17, 2013 ZOLL Medical Corporation Ms. Shannon Duhamel Regulatory Affairs Specialist 269 Mill Road Chelmsford, MA 01824 Re: K131919 Trade/Device Name: ZOLL ePCR iOS Regulation Number: 21 CFR 870.2450 Regulation Name: Medical Cathode-Ray Tube Display Regulatory Class: II Product Code: DXJ, NSX Dated: November 21, 2013 Received: November 22, 2013 Dear Ms. Duhamel: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {2}------------------------------------------------ . Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours, Kwame O. Ulmer -s FDA for Erin I. Keith, M.S. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ ## SECTION 4 - INDICATIONS FOR USE ### 510(k) Number (if known): ZOLL ePCR iOS Device Name: ### Intended Use: ZOLL ePCR iOS is intended for the collection, storage and printing of patient data that is entered by a user (caregiver), or captured from specified medical devices, and integrated into a patient care report (patient electronic medical record). ZOLL ePCR iOS is intended for use by qualified medical personnel providing direct patient care in the pre-hospital environment to document the care provided. ZOLL ePCR iOS is indicated for use by health care providers whenever there is a need for generation of a patient record. Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use __ X (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) ## Concurrence of CDRH, Office of Device Evaluation (ODE) FDA Digitally signed by Richard C. Chapman Date: 2013.12.17 12:50:56 -05'00' Page 1 of 1 {4}------------------------------------------------ Image /page/4/Picture/1 description: The image shows the word "ZOLL" in bold, black letters. The letters are blocky and sans-serif. A small registered trademark symbol is located to the right of the second "L". DEC 1 7 2013 EC 17 2013 ZOLL Medical Corporation Worldwide Headquarters 269 Mill Road Chelmsford, MA 01824 U.S.A. 978-421-9655 978-421-0025 Main Fax # 510(k) Summary: Submitter's Name and Address: ZOLL Medical Corporation 269 Mill Road Chelmsford, MA 01824-4105 (978) 421-9655 Contact Person: Shannon Duhamel (978) 421-9574 Date Summary Prepared: June 24, 2013 Device: ZOLL ePCR iOS Classification: Classification Product Code: 21 CFR 870.2450. Display, Cathode Ray Tube, Medical. Product code: DXJ. Device Class: 2. Secondary Product Code: Software, Transmission and Storage, Patient Data. Product code: NSX. Device Class: Not Classified. Description: The proposed ZOLL ePCR iOS is a software-only product. ZOLL ePCR iOS is a medical data collection system used to collect, store and print patient data that is entered by a user (caregiver), or captured from specified medical devices, and integrated into a patient care report (patient electronic medical record). ZOLL ePCR iOS is non-alarming software that runs on various iOS devices (iOS is the Apple operating system for use on iPads and iPhones). {5}------------------------------------------------ ### Intended Use: ZOLL ePCR iOS is intended for the collection, storage and printing of patient data that is entered by a user (caregiver), or captured from specified medical devices, and integrated into a patient care report (patient electronic medical record). ZOLL ePCR iOS is intended for use by qualified medical personnel providing direct patient care in the pre-hospital environment to document the care provided. ZOLL ePCR iOS is indicated for use by health care providers whenever there is a need for generation of a patient record. ### Substantial Equivalence: The features and functions of the proposed ZOLL ePCR iOS are substantially equivalent to the predicate device, ZOLL RescueNet ePCR (K103473), cleared for use on 05/13/2011. ### Comparison of Technological Characteristics ZOLL ePCR iOS features and functions are similar to the predicate device, Zoll RescueNet ePCR, except that the proposed device uses a different operating system. ZOLL ePCR iOS is a software application designed for use on iOS devices whereas the indicated predicate device operates on a tablet or webbased Microsoft Windows system. Both ZOLL ePCR iOS and the indicated predicate device are software-only products intended for the collection, storage and printing of patient data, including data that is entered by a user (caregiver) and data collected from other medical devices. Both ZOLL ePCR iOS and the indicated predicate device are indicated for use by health care providers whenever there is a need for generation of a patient record. Both the proposed device and the indicated predicate device are designed to synchronize to a data server using a wireless or network connection to import or access saved PCRs for completion at a convenient time. No new issues of safety or effectiveness are raised by this premarket notification. Performance Testing: Extensive performance testing ensures that ZOLL ePCR iOS performs as well as the indicated predicate device and meets all of its functional requirements and performance specifications. Conclusion The information provided in this 510(k) submission demonstrates that the features and functions of the proposed ZOLL ePCR iOS are substantially equivalent to the corresponding features and functions of the indicated commercially distributed predicate device with regard to performance, safety and effectiveness. ર-Σ
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...